€53.00+€0.05 (+0.09%)
Recordati Industria Chimica e Farmaceutica S.p.A.’s quoted price sits in the upper half of its reported 52-week range, 2.66% below the high.
Loading market information…
MIL · DIA.MI · EUR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 04:35 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
DiaSorin S.p.A.’s quoted price sits in the upper half of its reported 52-week range, 2.07% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
DiaSorin S.p.A.’s forward annual dividend is €1.30 per share, paid annual. The forward yield is 1.61% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
DiaSorin S.p.A.’s next earnings report is currently expected on Nov 5, 2026, with estimated earnings per share of €0.94. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow DiaSorin S.p.A.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:28 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 |
|---|
| May 8, 2025 |
| €0.96-13.51% vs estimate |
| €313.00M+0.99% vs estimate |
| Q4 2024 | Mar 13, 2025 | €0.82-24.17% vs estimate | €309.00M-2.03% vs estimate |
|---|
| Q3 2024 | Nov 5, 2024 | €0.84-4.55% vs estimate | €287.00M-9.68% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€53.00+€0.05 (+0.09%)
Recordati Industria Chimica e Farmaceutica S.p.A.’s quoted price sits in the upper half of its reported 52-week range, 2.66% below the high.
$20.24+$0.81 (+4.17%)
Stevanato Group S.p.A.’s quoted price sits in the upper half of its reported 52-week range, 25.04% below the high.
€13.07+€0.11 (+0.85%)
Amplifon S.p.A.’s quoted price sits in the upper half of its reported 52-week range, 13.36% below the high.
€16.40+€0.28 (+1.74%)
EL.En. S.p.A.’s quoted price sits in the upper half of its reported 52-week range, 7.03% below the high.
€1.94+€0.02 (+0.99%)
Safilo Group S.p.A.’s quoted price sits in the upper half of its reported 52-week range, 15.04% below the high.
€72.00+€0.70 (+0.98%)
Pharmanutra S.p.A.’s quoted price sits in the upper half of its reported 52-week range, 24.92% below the high.
€20.95-€0.05 (-0.24%)
Philogen S.p.A.’s quoted price sits in the lower half of its reported 52-week range, 19.42% below the high.
€15.12-€0.02 (-0.13%)
GPI S.p.A.’s quoted price sits in the lower half of its reported 52-week range, 19.06% below the high.
